The Prolia Class-action Lawsuit: What You Should Know
Most people do not know anything about a drug called Prolia and its treatment for menopausal osteoporosis. The problem with Prolia is that the medicine causes side effects similar to those associated with the actual disease. Personal injury lawyers recently filed a Prolia class-action lawsuit against Amgen, the manufacturer of the drug. Patients who have experienced severe injuries caused by Prolia should receive monetary compensation. Consequently, the Prolia recall led to the filing of a class-action lawsuit.
- 1 What are the side effects caused by Prolia?
- 2 What is the history of Prolia?
- 3 What are the common side effects associated with Prolia?
- 4 What is the status of the Prolia class-action lawsuit?
- 5 Who filed the petition to start a class-action lawsuit against Amgen?
- 6 Amgen knew about the scientific data associated with Prolia.
- 7 Amgen representatives told a different story to Europeans.
- 8 What is a class-action lawsuit?
- 9 Should previous users of Prolia join the class-action lawsuit?
What are the side effects caused by Prolia?
Many physicians recommend Prolia to their patients to treat osteoporosis, and numerous people experience positive results from taking the medication. Nevertheless, Prolia contains potentially harmful ingredients that may result in severe side effects, including hip fractures. Other side effects include bone and femur fractures.
What is the history of Prolia?
Amgen first introduced Prolia in 2010. The drug received immense popularity among doctors and patients. Consequently, the U.S. Food and Drug Administration (FDA) approved Prolia to treat postmenopausal osteoporosis. Alendronate was the previously favored medication for treating symptoms related to osteoporosis.
Introduced in 1995, Alendronate also contained ingredients that could result in severe bone fractures. Some patients mentioned that the drug prevented them from standing. Accordingly, the FDA published warnings on labels. These warnings said that Alendronate might cause unexpected bone fractures.
Cancer patients who take Prolia use it with the understanding that the drug may improve bone mass. Some physicians tell their cancer patients to take Prolia in combination with other prescribed medicines. The recent Prolia class-action lawsuit mentions other drugs, including antineoplastics, endocrine drugs, and monoclonal antibodies. Furthermore, scientists do not know if younger children can take Prolia without experiencing any dangerous side effects.
What are the common side effects associated with Prolia?
The possibility of experiencing severe adverse reactions makes it impossible for patients to avoid the fact that they are taking huge risks if they decide to use Prolia. Some people have died after using Prolia. Side effects associated with this drug include dry skin that peels, severe joint pain, bone pain, and pain in the thighs.
What is the status of the Prolia class-action lawsuit?
Public demand has resulted in an important decision rendered by personal injury attorneys to file a class-action lawsuit against Amgen. The drug manufacturer’s representatives did not inform the FDA or the public about the drug’s potential to cause severe side effects. In addition, product liability attorneys conducted their investigations into the damages caused by Prolia.
In 2012, Health Canada and Amgen representatives issued an official statement to the public. The information expressed concerns that patients who used Prolia had experienced severe adverse reactions to the drug, including bone fractures. It is important to remember that Amgen developed the drug to treat osteoporosis rather than cause symptoms similar to those associated with the progressive disease.
Who filed the petition to start a class-action lawsuit against Amgen?
First Citizen, a public consumer watchdog group, filed an official document with the FDA expressing complaints about Prolia. First Citizen petitioned the FDA for a Prolia recall. First Citizen asked the FDA to force Amgen to conduct the recall so that doctors and patients would not have access to the drug. Research demonstrated that Prolia caused fractured vertebrae. In addition, First Citizen requested that Amgen include an official “black box warning” on the Prolia label explaining that taking this medicine could cause severe bone fractures.
First Citizen asked the FDA to grant more extensive protection to patients taking Prolia after scientists decided that the medication caused the risk of experiencing broken vertebrae. According to the petition filed by First Citizen, Amgen deliberately hid known data from the public about the prescribed medication’s potential to cause broken vertebrae, insisting that the manufacturer refused to include this warning on the label. According to First Citizen, known information about possibly dangerous side effects must show on the drug’s packaging material so that doctors and patients know about the hidden dangers.
Amgen knew about the scientific data associated with Prolia.
An Amgen representative stated that the company knew about the research showing that patients using Prolia had risks of developing fractured vertebrae. Nonetheless, the same representative then stated that taking the drug outweighed any associated risks. The spokesperson said that Amgen was working with FDA regulators to ensure that people who used to take Prolia may have experienced bone fractures. First Citizen insists that the FDA is not doing enough to notify physicians and patients about the risks associated with using Prolia.
Amgen representatives told a different story to Europeans.
After First Citizen filed an initial complaint in Europe, Amgen advised people in the United States to continue using Prolia. Amgen did not warn doctors and patients in the United States about the drug’s potential to cause fractures. Attorneys involved in the Prolia class-action lawsuit then studied the available data to determine if patients should receive monetary compensation due to product liability issues.
What is a class-action lawsuit?
Anyone who has taken Prolia should consult with a personal injury lawyer regarding whether they qualify for monetary compensation via the class-action lawsuit. A class-action lawsuit includes many members who are eligible for compensation because they all took the drug. A class-action lawsuit typically ensues when a large percentage of the population qualifies for damages. A lead plaintiff must show the court that all members meet the qualifications and that each person has experienced the same adverse side effects.
Should previous users of Prolia join the class-action lawsuit?
In addition to causing severe bone fractures, some patients taking Prolia were diagnosed with esophageal cancer. Amgen deliberately deceived the public by hiding vital facts about the safety associated with using Prolia. All patients who previously used Prolia should become members of the class-action lawsuit. People who choose to participate in the class-action lawsuit may eventually receive compensation because they decided to become members.
Drug manufacturers have accountability to the public. Moral ethics imply that a manufacturer must inform people if a drug created to treat a disease causes more severe problems upon its use. Accountability means that people need complete information about a drug’s possible dangers before the manufacturer sells a medication. Amgen did not reveal significant data and ended up experiencing a Prolia recall and class-action lawsuit.